| Style | Citing Format |
|---|---|
| MLA | Shirazian S, et al.. "Preliminary Study of Androgen Receptor Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma: A Comparative Cross-Sectional Analysis." Cancer Treatment and Research Communications, vol. 46, no. , 2026, pp. -. |
| APA | Shirazian S, Tehranchi S, Mahdavi N, Kharazifard MJ, Moosavi MS (2026). Preliminary Study of Androgen Receptor Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma: A Comparative Cross-Sectional Analysis. Cancer Treatment and Research Communications, 46(), -. |
| Chicago | Shirazian S, Tehranchi S, Mahdavi N, Kharazifard MJ, Moosavi MS. "Preliminary Study of Androgen Receptor Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma: A Comparative Cross-Sectional Analysis." Cancer Treatment and Research Communications 46, no. (2026): -. |
| Harvard | Shirazian S et al. (2026) 'Preliminary Study of Androgen Receptor Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma: A Comparative Cross-Sectional Analysis', Cancer Treatment and Research Communications, 46(), pp. -. |
| Vancouver | Shirazian S, Tehranchi S, Mahdavi N, Kharazifard MJ, Moosavi MS. Preliminary Study of Androgen Receptor Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma: A Comparative Cross-Sectional Analysis. Cancer Treatment and Research Communications. 2026;46():-. |
| BibTex | @article{ author = {Shirazian S and Tehranchi S and Mahdavi N and Kharazifard MJ and Moosavi MS}, title = {Preliminary Study of Androgen Receptor Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma: A Comparative Cross-Sectional Analysis}, journal = {Cancer Treatment and Research Communications}, volume = {46}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Shirazian S AU - Tehranchi S AU - Mahdavi N AU - Kharazifard MJ AU - Moosavi MS TI - Preliminary Study of Androgen Receptor Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma: A Comparative Cross-Sectional Analysis JO - Cancer Treatment and Research Communications VL - 46 IS - SP - EP - PY - 2026 ER - |